Harvard-wide Pediatric Health Services Research Fellowship Program
Jonathan A Finkelstein, MD, MPH.
Vice Chair for Quality and Outcomes, Dept. of Medicine, Children’s Hospital Boston; Associate Professor of Pediatrics and of Population Medicine, Harvard Medical School; Co-Director of the Program.
Dr. Finkelstein is a health services researcher and educator who, with Dr. Goldmann, is responsible for overall direction of the program, and mentorship of its trainees. Dr. Finkelstein focuses both his teaching and research at the overlap between clinical care quality and the health of large populations. He has utilized managed care systems to test care improvement strategies for childhood asthma and to study asthma care for low-income children. He has also analyzed changing patterns of antibiotic use for children, and has led a randomized trial of a community-based approach to promoting appropriate antibiotic use. He is Principal Investigator of an NIH-funded study to measure changes in pneumococcal carriage and infection in the era of pneumococcal immunization, and another to analyze continuing changes in antibiotic use in primary care practice. In his role as Vice Chair for Quality and Outcomes, Dr. Finkelstein is responsible for quality measurement and improvement activities in the Dept. of Medicine, and for building a program for academic work related to pediatric health care quality. Dr. Finkelstein has also had leadership roles in undergraduate, graduate, and post-graduate medical education. Currently, he directs Clinical Epidemiology and Population Health, a required course for Harvard Medical School students. In addition, he practices as a general pediatrician at Children's Hospital.
Original Research (selected from 95 peer-reviewed research reports)
- Finkelstein JA, Stille C, Nordin J, Davis R, Raebel MA, Roblin D, Go A, Smith D, Johnson CC, Kleinman K, Chan KA, Platt R. Decreasing antibiotic use among US children: the impact of changing diagnosis patterns. Pediatrics 2003; 112:620-627.
- Stille CJ, Andrade SE, Huang S, Nordin J, Raebel MA, GO AS, Chan KA, Finkelstein JA. Increased use of second-generation macrolide antibiotics for children in nine US health plans. Pediatrics 2004; 114:1206-1211.
- Finkelstein JA, Lozano P,Fuhlbrigge AL, Carey VJ, Inui TS, Soumerai SB, Sullivan SD, Wagner EH, Weiss ST, Weiss KB. Practice-level effects of interventions to improve asthma care in primary care settings: the Pediatric Asthma Care PORT. Health Services Research 2005 40:1737-57.
- Gupta RS, Shuman S, Taveras E, KulldorffM, Finkelstein JA. Opportunities for health promotion education in child care. Pediatrics 2005 116:e499-e505.
- Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic treatment of children with sore throat in the United States. 2005 JAMA 294:2315-22.
- Taveras EM, LaPelle N, Gupta RS, Finkelstein JA. Planning for health promotion in low-income preschool child care settings: focus groups of parents and child care providers. Ambulatory Pediatrics 2006 6:342-6
- Gupta RS, Bewtra M, Prosser LA, Finkelstein JA. Predictors of hospital charges for children admitted with asthma. Ambulatory Pediatrics 2006 6:15-20.
- Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J, Huang SS, Goldstein R, Hanage WP. Emergence of 19A as virulent and multidrug resistant in Massachusetts following universal immunization of infants with PCV7. Pediatric Infectious Disease Journal. 2007; 26(6): 468-72.
- Huang SS, Rifas-Shiman SL, Kleinman K, Kotch J, Schiff N, Stille CJ, Steingard R, Finkelstein JA. Parental knowledge about antibiotic use: results of a cluster-randomized multi-community intervention. Pediatrics 2007; 119:698-706.
- Finkelstein JA, Huang SS, Kleinman K, Rifas-Shiman SL, Stille CJ, Daniel J, Schiff N, Steingard R, Soumerai SB, Ross-Degnan D, Goldmann D, Platt R. Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics. 2008;121(1):e15-23.
- Toomey SL, Homer CJ, Finkelstein JA. Comparing Medical Homes for Children with ADHD and Asthma. Academic Pediatrics. 2010 Jan-Feb;10(1):56-63.
- Costa MA, Huang SS, Moore M, Kulldorff M, Finkelstein JA. New approaches to estimating national rates of invasive pneumococcal disease. Am J Epidemiology 2011; in press.
- Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, Finkelstein JA. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine. 2011 29(18): 3398-3412.Epub 2010 Mar 10.